Flushing away the poo taboo, together!
What is it that stops us from talking about our digestive health, or poo, as openly as we’d talk about having a cold, a headache or back pain? After all, our poo is an indication...
7th March 2024
16th May 2021
Guts UK is proud to be a part of World Barrett’s Oesophagus Day on the 16th May 2021.
Barrett’s oesophagus is a term used for pre-cancerous condition where the normal cells that line the oesophagus (food pipe) have been replaced with abnormal cells. The main concern is, although the vast majority of patients with Barrett’s oesophagus don’t progress to oesophageal cancer, they will still require monitoring.
It is thought that 10% of persistent heartburn sufferers who have longstanding reflux problems may develop Barrett’s oesophagus.
The main symptom is reflux, which can cause heartburn, nausea, pain in the upper abdomen and even regurgitation of food. People also experience a metallic taste in the mouth or a chronic sore throat.
Often though, people don’t report any symptoms or may manage with over the counter antacids (PPI’s) which can delay the diagnosis of Barrett’s oesophagus.
Early on in 2020, John started to feel full after eating small amounts of food. John’s wife, Pam had noticed that he was losing weight quite quickly too.
Pam had sadly lost a family member to oesophageal cancer years prior, so when she recognised her husbands’ symptoms, she urged him to talk to his doctor.
John didn’t delay. He made an appointment to tell his GP about his symptoms. His GP made an urgent referral for John to have an endoscopy. Shortly afterwards, John was diagnosed with oesophageal cancer. Read the rest of John’s story.
Yes. Monitoring Barrett’s oesophagus is a vital and lifelong part of treatment. Around 3 to 13 out of 100 people with Barrett’s oesophagus will go on to develop oesophageal cancer in their lifetime. Therefore, although the lifetime risk is low, those with Barrett’s oesophagus are at a higher risk of developing oesophageal cancer than the general population.
Those with Barrett’s oesophagus are usually entered into a surveillance programme which ensures regular and appropriate monitoring, usually by endoscopy. How often these endoscopies are depends, and varies from person to person.
Endoscopies can be a quite unpleasant experience for patients. Even more so for those with Barrett’s oesophagus who encounter them more frequently to monitor their condition. It is also costly for the NHS, at £1,500 per endoscopy.
It is important to determine patients at risk, with the ultimate goal of targeting endoscopy towards the people at high risk of developing cancer.
Guts UK is proud to fund Dr Jamel’s research, looking to introduce a non-invasive and cost-effective way to monitor those with Barrett’s oesophagus through a ‘breath-test’.
Only 15 out of 100 people diagnosed will survive oesophageal cancer for 5 years or more, yet 59% of cases are preventable.
If successful, this breath test could save lives by diagnosing oesophageal cancer early, using a simple test, when it’s far more treatable.
What is it that stops us from talking about our digestive health, or poo, as openly as we’d talk about having a cold, a headache or back pain? After all, our poo is an indication...
7th March 2024
You might know of the Guts UK charity legend, Colin the Inflatable Colon, but if this is your first time hearing of him, fear not, because you are in for a treat! Let’s get to...
20th March 2024
Tell us a bit about you “I’m Mia and I’m 32. I’m a housewife, living in Birmingham and I’m originally from Sheffield. I was very career focused but due to my health, this took a...
13th March 2024
By submitting this form, you are consenting to Guts UK contacting you by email as detailed above. To make any changes to your preferences you can email us on info@gutscharity.org.uk or by calling us on 020 7486 0341. Your details are safe with us. Please read our Privacy Policy for more details.